 JERUSALEM, Jan. 21, 2021 PRNewswire -- BiondVax Pharmaceuticals Ltd. Nasdaq: BVXV, a biopharmaceutical company focused on development and manufacturing of products for the prevention and treatment of infectious diseases, today announced the appointment of Amir Reichman as its new CEO... 